Myositis due to Sorafenib intake in a patient with hepatocellular carcinoma. [electronic resource]
Producer: 20110727Description: 333-4 p. digitalISSN:- 1878-3562
- Antineoplastic Agents -- adverse effects
- Benzenesulfonates -- adverse effects
- Carcinoma, Hepatocellular -- drug therapy
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Myositis -- chemically induced
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- adverse effects
- Sorafenib
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.